MENU
Showcases Stock ranks Forex

Ascendis Pharma ADR (ASND)
98.93  4.02 (4.24%) 08-08 16:00
Open: 95.28 Pre. Close: 94.91
High: 99.99 Low: 94.96
Volume: 1,369,387 Market Cap: 5,636M
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 100.05 - 100.346 100.346 - 100.677
Low: 94.084 - 94.436 94.436 - 94.83
Close: 98.29 - 98.838 98.838 - 99.451
Stock Technical Analysis
Overall:     
Target: Six months: 116.79
One year: 136.41
Support: Support1: 89.30
Support2: 82.70
Resistance: Resistance1: 99.99
Resistance2: 116.79
Pivot: 89.15
Moving Averages: MA(5): 92.25
MA(20): 88.62
MA(100): 94.85
MA(250): 120.52
MACD: MACD(12,26): 0.99
Signal(12,26,9): -0.12
%K %D: %K(14,3): 92.72
%D(3): 82.18
RSI: RSI(14): 66.93
52-Week: High: 178.71
Low: 61.579
Change(%): -14.9
Average Vol(K): 3-Month: 389
10-Days: 475
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ ASND ] has closed Bollinger Bands are 21.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Mon, 19 Oct 2020
European ADRs Move Higher in Monday Trading - InvestorsObserver

Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Wed, 31 Dec 1969


Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 56.97
% Held by Insiders 43190000.00
% Held by Institutions 0.07
Shares Short (K) 5930
Shares Short Prior Month (K)
Stock Financials
EPS -450489984.000
Book Value (p.s.)
Profit Margin
Operating Margin -3.00
Return on Assets (ttm) 284.1
Return on Equity (ttm) -24.3
Qtrly Rev. Growth 13860000.0
Gross Profit (p.s.) 1216.866
Sales Per Share -90.284
EBITDA (p.s.) 6343283.500
Qtrly Earnings Growth -8.46
Operating Cash Flow (M)
Levered Free Cash Flow (M) -466.82
Stock Valuation
PE Ratio
PEG Ratio 8.32
Price to Book value
Price to Sales -1.10
Price to Cash Flow 5.50
Stock Dividends
Dividend
Dividend Yield
Dividend Growth 6870000.000

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android